Skip to content

Clinical trials

Phase 3 Mycoses trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mycoses Phase: Phase 3 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20043
20061
20071
20092
20102
20114
20131
20181
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
National Institute of Allergy and Infectious Diseases (NIAID)5
Children's Oncology Group3
Pfizer3
Basilea Pharmaceutica2
Merz North America, Inc.2
University of California, San Francisco2
University of Pittsburgh2
Astellas Pharma Inc1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mycoses29
Candidiasis9
Candidemia6
Fungemia6
Invasive Fungal Infections6
Candidiasis, Invasive5
Aspergillosis3
HIV Infections3
Infections3
Neutropenia3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.